163 related articles for article (PubMed ID: 36370147)
21. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
Kaplowitz PB; Jiang J; Vaidyanathan P
J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
[TBL] [Abstract][Full Text] [Related]
22. Thyroid function after subtotal thyroidectomy in patients with Graves' hyperthyroidism.
Limonard EJ; Bisschop PH; Fliers E; Nieveen van Dijkum EJ
ScientificWorldJournal; 2012; 2012():548796. PubMed ID: 22448136
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M
World J Surg; 1992; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
[TBL] [Abstract][Full Text] [Related]
26. Postradioiodine Graves' management: The PRAGMA study.
Perros P; Basu A; Boelaert K; Dayan C; Vaidya B; Williams GR; Lazarus JH; Hickey J; Drake WM; Crown A; Orme SM; Johnson A; Ray DW; Leese GP; Jones TH; Abraham P; Grossman A; Rees A; Razvi S; Gibb FW; Moran C; Madathil A; Žarković MP; Plummer Z; Jarvis S; Falinska A; Velusamy A; Sanderson V; Pariani N; Atkin SL; Syed AA; Sathyapalan T; Nag S; Gilbert J; Gleeson H; Levy MJ; Johnston C; Sturrock N; Bennett S; Mishra B; Malik I; Karavitaki N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):664-675. PubMed ID: 35274331
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of hyperthyroidism.
Quérat C; Germain N; Dumollard JM; Estour B; Peoc'h M; Prades JM
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Apr; 132(2):63-6. PubMed ID: 25592327
[TBL] [Abstract][Full Text] [Related]
28. Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease?
Tamatea JA; Tu'akoi K; Conaglen JV; Elston MS; Meyer-Rochow GY
ANZ J Surg; 2014 Apr; 84(4):231-4. PubMed ID: 22985335
[TBL] [Abstract][Full Text] [Related]
29. Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
Nonchev BI; Terzieva DD; Dimov RS; Mateva NG; Tsvetkova TZ; Dimitrakov DY
Folia Med (Plovdiv); 2005; 47(3-4):40-5. PubMed ID: 16761393
[TBL] [Abstract][Full Text] [Related]
30. Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
Jin M; Jang A; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
PLoS One; 2022; 17(3):e0265332. PubMed ID: 35275968
[TBL] [Abstract][Full Text] [Related]
31. Thyroidectomy for Graves' disease in children: Indications and complications.
Elfenbein DM; Katz M; Schneider DF; Chen H; Sippel RS
J Pediatr Surg; 2016 Oct; 51(10):1680-3. PubMed ID: 27113266
[TBL] [Abstract][Full Text] [Related]
32. Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial.
Witte J; Goretzki PE; Dotzenrath C; Simon D; Felis P; Neubauer M; Röher HD
World J Surg; 2000 Nov; 24(11):1303-11. PubMed ID: 11038198
[TBL] [Abstract][Full Text] [Related]
33. Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy.
Bobanga ID; McHenry CR
Best Pract Res Clin Endocrinol Metab; 2019 Aug; 33(4):101319. PubMed ID: 31530446
[TBL] [Abstract][Full Text] [Related]
34. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
Mori Y; Matoba N; Miura S; Sakai N; Taira Y
World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
[TBL] [Abstract][Full Text] [Related]
35. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
[TBL] [Abstract][Full Text] [Related]
36. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
[TBL] [Abstract][Full Text] [Related]
37. Disease impacts more than age on operative morbidity in children with Graves' disease after total thyroidectomy.
Machens A; Elwerr M; Schneider R; Lorenz K; Dralle H
Surgery; 2018 Nov; 164(5):993-997. PubMed ID: 30174139
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
39. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
40. Radioiodine treatment of recurrent hyperthyroidism in patients previously treated for Graves' disease by subtotal thyroidectomy.
Vestergaard H; Laurberg P
J Intern Med; 1992 Jan; 231(1):13-7. PubMed ID: 1732393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
